GABRG2 rs55712126‐G and C11orf21 rs77007065‐A are associated with higher (OR = 1.62, P = 2.88E‐06) and lower AD risk (OR = 0.68, P = 9.78E‐06), respectively, in MAPT H2 carriers (Table 2). This evidence concerns the gene MAPT and Alzheimer disease.